Javascript must be enabled to continue!
Clinical Efficacy of Chinese Medicine in Treating Adult Henoch–Schönlein Purpura: A Meta‐Analysis
View through CrossRef
Introduction
This meta‐analysis evaluates the efficacy of traditional Chinese medicine, alone or in combination with Western medicine, for the treatment of adult Henoch–Schönlein purpura.
Methods
We searched clinical randomized controlled trials on the treatment of adult Henoch–Schönlein purpura with traditional Chinese medicine from the Chinese Journal Literature Database (CNKI), Wanfang Database, Embase, PubMed, Cochrane, Scopus, the Journal of Pharmacopuncture, and the National Library of China. After removing duplicate literature and reviewing titles, we selected the final studies based on our inclusion and exclusion criteria. These studies were assessed for bias using the Cochrane risk of bias assessment tool, and statistical analysis was performed using Review Manager 5.3.0 software. The PRISMA guidelines were followed when conducting the meta‐analysis.
Results
Eighteen studies were included, with a combined sample size of 1632 cases, including 811 in the experimental group and 821 in the control group. The results indicated that traditional Chinese medicine, whether used alone or in combination with Western medicine, was more effective than Western medicine alone in terms of overall effectiveness and improvement in skin purpura, digestive tract, and joint symptoms. We found that the total clinical effective rate of patients in the experimental group was higher than that of the control group (OR = 6.04, 95% CI [4.01, 9.10],
p
< 0.001). Meta‐analysis indicates that the difference between the control and experimental groups in improving skin purpura symptoms is statistically significant (SMD = −1.09, 95% CI [−1.22, −0.96],
p
< 0.001). We found that a more significant improvement occurred in the experimental group than in the control group (SMD = −0.95, 95% CI [−1.08, −0.82],
p
< 0.001). People in the experimental group showed a greater decrease in joint symptoms than those in the control group (SMD = −0.95, 95% CI [−1.08, −0.82],
p
< 0.001).
Conclusion
Traditional Chinese medicine, either alone or combined with Western medicine, is more effective than Western medicine alone in treating Henoch–Schönlein purpura. It also shows superior efficacy in improving skin purpura, digestive tract, and joint symptoms.
Title: Clinical Efficacy of Chinese Medicine in Treating Adult Henoch–Schönlein Purpura: A Meta‐Analysis
Description:
Introduction
This meta‐analysis evaluates the efficacy of traditional Chinese medicine, alone or in combination with Western medicine, for the treatment of adult Henoch–Schönlein purpura.
Methods
We searched clinical randomized controlled trials on the treatment of adult Henoch–Schönlein purpura with traditional Chinese medicine from the Chinese Journal Literature Database (CNKI), Wanfang Database, Embase, PubMed, Cochrane, Scopus, the Journal of Pharmacopuncture, and the National Library of China.
After removing duplicate literature and reviewing titles, we selected the final studies based on our inclusion and exclusion criteria.
These studies were assessed for bias using the Cochrane risk of bias assessment tool, and statistical analysis was performed using Review Manager 5.
3.
0 software.
The PRISMA guidelines were followed when conducting the meta‐analysis.
Results
Eighteen studies were included, with a combined sample size of 1632 cases, including 811 in the experimental group and 821 in the control group.
The results indicated that traditional Chinese medicine, whether used alone or in combination with Western medicine, was more effective than Western medicine alone in terms of overall effectiveness and improvement in skin purpura, digestive tract, and joint symptoms.
We found that the total clinical effective rate of patients in the experimental group was higher than that of the control group (OR = 6.
04, 95% CI [4.
01, 9.
10],
p
< 0.
001).
Meta‐analysis indicates that the difference between the control and experimental groups in improving skin purpura symptoms is statistically significant (SMD = −1.
09, 95% CI [−1.
22, −0.
96],
p
< 0.
001).
We found that a more significant improvement occurred in the experimental group than in the control group (SMD = −0.
95, 95% CI [−1.
08, −0.
82],
p
< 0.
001).
People in the experimental group showed a greater decrease in joint symptoms than those in the control group (SMD = −0.
95, 95% CI [−1.
08, −0.
82],
p
< 0.
001).
Conclusion
Traditional Chinese medicine, either alone or combined with Western medicine, is more effective than Western medicine alone in treating Henoch–Schönlein purpura.
It also shows superior efficacy in improving skin purpura, digestive tract, and joint symptoms.
Related Results
Henoch-Schonlein Purpura (HSP)
Henoch-Schonlein Purpura (HSP)
Abstract—Henoch-Schonlein purpura (HSP) is a systemic vasculitic disease (vascular inflammation) characterized by the deposition of immune complexes consisting of IgA in kidney ski...
AGE RELATED CHARACTERISTICS OF CHILDREN AND ADOLESCENT WITH HENOCH SCHÖNLEIN PURPURA AND SYSTEMS INVOLVEMENT: AN EXPERIENCE FROM TERTIARY CARE CENTER
AGE RELATED CHARACTERISTICS OF CHILDREN AND ADOLESCENT WITH HENOCH SCHÖNLEIN PURPURA AND SYSTEMS INVOLVEMENT: AN EXPERIENCE FROM TERTIARY CARE CENTER
Background: Henoch-Schönlein Purpura (HSP) is the most common vasculitis among children and adolescent characterized by skin, joints, renal and gastrointestinal involvement. There ...
Henoch-Schonlein Purpura in Children at Department of Pediatric, Bach Mai Hospital
Henoch-Schonlein Purpura in Children at Department of Pediatric, Bach Mai Hospital
Objectives: To identify the percentage of parents having the correct knowledge of caring their children and evaluable quality of life in children with chronic kidney diseases. Subj...
Gastrointestinal Dominant Henoch Schönlein Purpura in Children: A Report of Two Cases
Gastrointestinal Dominant Henoch Schönlein Purpura in Children: A Report of Two Cases
Background: Henoch Schönlein Purpura (HSP) is the most common vasculitis in children, characterized by purpura, arthritis, gastrointestinal involvement, and nephritis. Gastrointest...
Pulmonary haemorrhage and pleural effusion in an elderly patient with Henoch-Schönlein purpura (IgA vasculitis)-: a case report
Pulmonary haemorrhage and pleural effusion in an elderly patient with Henoch-Schönlein purpura (IgA vasculitis)-: a case report
Henoch-Schönlein purpura (HSP) also known as IgA vasculitis is a systemic small vessel vasculitis mainly affecting the skin, kidneys, joints, and gastrointestinal tract. However, t...
Púrpura de Henoch-Schönlein – Um relato de caso na Atenção Primária
Púrpura de Henoch-Schönlein – Um relato de caso na Atenção Primária
Objetivo: relatar um caso de Púrpura de Henoch-Schönlein, em uma criança de 4 anos de idade que apresentou quadro de edema e exantema purpúrico palpável em membros inferiores, asso...
Abdominal wall and labial edema presenting in a girl with Henoch-Schönlein purpura: a case report
Abdominal wall and labial edema presenting in a girl with Henoch-Schönlein purpura: a case report
Abstract
Introduction
Henoch-Schönlein purpura is a common immunoglobulin A-mediated vasculitic syndrome in children, characterized by purpuric r...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...

